IHL 0.00% 4.1¢ incannex healthcare limited

Ann: Clinical Progress on IHL-216A for TBI and CTE, page-27

  1. 6,825 Posts.
    lightbulb Created with Sketch. 1727
    Lupe, wouldn't worry about that, success in these trials would mean a staggering rerate. Besides, the options add considerable cash to the Company meaning less or no need for CR down the track. It is already factored in given they are in the money.
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.